Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa

Conditions: HIV Interventions: Drug: Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA); Drug: Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC) Sponsors: MRC/UVRI and LSHTM Uganda Research Unit; King ' s College London; London School of Hygiene and Tropical Medicine; Africa Health Research Institute; Wits Health Consortium (Pty) Ltd; University College, London; Ministry of Health, Uganda; Desmond Tutu HIV Foundation; Assistance Publique - H ôpitaux de Paris Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials